US Patent Issued to ENTEROBIOME on May 12 for "Pharmaceutical composition for preventing or treating atopic disease containing Faecalibacterium prausnitzii strain" (South Korean Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,934, issued on May 12, was assigned to ENTEROBIOME INC. (Goyang-si, South Korea).

"Pharmaceutical composition for preventing or treating atopic disease containing Faecalibacterium prausnitzii strain" was invented by Jae-Gu Seo (Gimpo-si, South Korea), Joo-Hyun Shin (Seoul, South Korea), Dokyung Lee (Seoul, South Korea), Yoonmi Lee (Seoul, South Korea), Seo Yul Jang (Goyang-si, South Korea) and Hye Rim Byeon (Paju-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical composition effective for the prevention or treatment of atopic disease is disclosed. The pharmaceutical composition contains a Faecalibacterium prausnitzii EB-F...